#read

Berlin invests in Bayer Charité Centre for Gene and Cell Therapies

The Berlin Senate has approved funding of 25.5 million euros for the planned Bayer Charité Centre for Gene and Cell Therapies. A start-up incubator will be built on three floors of the new centre at Nordhafen, which will provide space for up to 20 start-ups. The aim is to make Berlin the leading centre of innovation for gene and cell therapies.

19/08/2025

The centre will research novel approaches to cancer and Parkinson's disease and link them to clinical development. Together with Bayer, Charité, the federal government and the state of Berlin, the aim is to build a bridge between science and industry in order to develop marketable therapies from cutting-edge research. A 6,000 square metre area with up to 350 workplaces for young companies is planned. The incubator will function like an incubator in which start-ups can grow until they are strong enough to stand on their own. Construction is scheduled to start in autumn, with the first companies moving in in 2028.

News of "rbb" from 19.08.2025

The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.

Click here to access the original content